Charlie Harris

Charlie Harris works at the intersection of AI and biology, developing models for structure-based drug discovery: using molecular structures to guide potential medicines. At Boltz, he works on foundation and generative models for molecular design. He previously helped shape the UK’s AI for Science strategy and launch OpenBind, a protein–ligand dataset initiative.